Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study (Q40620063)

22 September 2017

Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study (English)

1 reference

22 September 2017

Jennifer K King

1

1 reference

22 September 2017

Shiou-Hwei Yeh

2

1 reference

22 September 2017

Ming-Wei Lin

3

1 reference

22 September 2017

Chun-Jen Liu

4

1 reference

22 September 2017

Ming-Yang Lai

5

1 reference

22 September 2017

Jia-Horng Kao

6

1 reference

22 September 2017

Ding-Shinn Chen

7

1 reference

22 September 2017

Pei-Jer Chen

8

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

22 September 2017

1 reference

22 September 2017

36

1 reference

22 September 2017

1416-1424

1 reference

22 September 2017

6

1 reference

Generation of a mutant form of protein synthesis initiation factor eIF-2 lacking the site of phosphorylation by eIF-2 kinases

22 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Current treatment strategies for chronic hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Hepatitis B genotypes and the response to interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

HLA-DRB1*1301 AND *1302 protect against chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Host-pathogen interactions in emerging and re-emerging infectious diseases: a genomic perspective of tuberculosis, malaria, human immunodeficiency virus infection, hepatitis B, and cholera

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Immunological studies before and during interferon therapy in chronic HBV infection: identification of factors predicting response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Antiviral actions of interferons

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

STATs and gene regulation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Transmission/disequilibrium tests for extended marker haplotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Monte Carlo tests for associations between disease and alleles at highly polymorphic loci

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Mechanism of interferon action: Phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

RNAi targeting an animal virus: news from the front

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Isolation and characterization of the promoter and flanking regions of the gene encoding the human protein-synthesis-initiation factor 2 alpha

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Mx proteins: mediators of innate resistance to RNA viruses.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Inhibition of influenza C viruses by human MxA protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

New developments in high-throughput resequencing and variation detection using high density microarrays

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Accessing single nucleotide polymorphisms in genomic DNA by direct multiplex polymerase chain reaction amplification on oligonucleotide microarrays.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Methods for genotyping single nucleotide polymorphisms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840360618

7 January 2021

Identifiers

DOI

10.1002/HEP.1840360618

1 reference

22 September 2017

1 reference